MOUNTAIN VIEW, Calif., Aug. 5, 2014 /PRNewswire/ -- IRIDEX Corporation (NASDAQ: IRIX) today announced that President and CEO Will Moore is scheduled to make an investor presentation at the 2014 Wedbush Life Sciences Management Access Conference at 1:55 p.m. Eastern Time on Tuesday, August 12, in New York City. In addition, Mr. Moore will participate on a panel at the conference discussing Ophthalmology Treatments & Tools at 11:30 a.m. Eastern Time on Tuesday, August 12th.
A live audio webcast of the investor presentation will be available in the Investors section of the IRIDEX website at http://www.iridex.com/.
IRIDEX Corporation was founded in 1989 and is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. We maintain a deep commitment to the success of our customers, with comprehensive technical, clinical, and service support programs. IRIDEX is dedicated to a standard of excellence, offering superior technology for superior results. IRIDEX products are sold in the United States through both direct and independent sales forces and internationally through a combination of a direct sales force and a network of approximately 70 independent distributors into over 100 countries. For further information, visit the Company's website at http://www.iridex.com.
SOURCE IRIDEX Corporation